<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - Roche</title>
<description>International Business News - Roche</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Memory selling to partner Roche for $50 million</title>
  <description>Memory Pharmaceuticals Corp. said Tuesday Swiss drug developer Roche will buy the biotech company for about $50 million, in a move to bulk up its development of potential Alzheimer's disease and schizophrenia treatments.</description>
    <link>http://www.ibtimes.com/articles/20081125/memory-selling-to-partner-roche-for-50-million.htm</link> 
  <pubDate>Tue, 25 Nov 2008 06:49:23 EST</pubDate>
  </item>


  <item>
  <title>Roche ordered to pay $13M to users of acne drug</title>
  <description>A jury has ordered drugmaker Roche to pay nearly $13 million to three patients who claim they developed a chronic bowel disorder because of the company's acne drug Accutane.</description>
    <link>http://www.ibtimes.com/articles/20081120/roche-ordered-to-pay-13m-to-users-of-acne-drug.htm</link> 
  <pubDate>Thu, 20 Nov 2008 13:09:16 EST</pubDate>
  </item>


  <item>
  <title>Roche sales up 1.6 percent in third quarter</title>
  <description>Roche Holding AG reported a 1.6 percent rise in third-quarter sales Tuesday, as a good market for its cancer medicines was partly offset by currency effects and fewer orders for flu drug Tamiflu.</description>
    <link>http://www.ibtimes.com/articles/20081021/roche-sales-up-1-6-percent-in-third-quarter.htm</link> 
  <pubDate>Tue, 21 Oct 2008 13:26:45 EDT</pubDate>
  </item>


  <item>
  <title>Roche plans to close Palo Alto lab</title>
  <description>Swiss drug maker Roche is planning to shutter its 1,000-worker Palo Alto research lab as it pursues its takeover bid for Genentech Inc. A Roche Palo Alto spokeswoman said the 1-million-square-foot facility's inflammation research unit will move to Nutley, N.J., Roche's current U.S. headquarters.</description>
    <link>http://www.ibtimes.com/articles/20080904/roche-plans-to-close-palo-alto-lab.htm</link> 
  <pubDate>Thu, 04 Sep 2008 19:18:40 EDT</pubDate>
  </item>


  <item>
  <title>Roche plans to close 1,000-worker California lab</title>
  <description>Swiss drug maker Roche is planning to shutter its 1,000-worker Palo Alto research lab as it pursues its takeover bid for Genentech Inc. A Roche Palo Alto spokeswoman said the 1-million-square-foot facility's inflammation research unit will move to Nutley, N.J., Roche's current U.S. headquarters.</description>
    <link>http://www.ibtimes.com/articles/20080904/roche-plans-to-close-1-000-worker-california-lab.htm</link> 
  <pubDate>Thu, 04 Sep 2008 19:12:27 EDT</pubDate>
  </item>


  <item>
  <title>Genentech retention plan to cost $371 million</title>
  <description>A Genentech employee retention plan announced along with its rejection of Roche's buyout offer will cost the biotechnology giant about $371 million, according to documents filed Thursday with the Securities and Exchange Commission.</description>
    <link>http://www.ibtimes.com/articles/20080821/genentech-retention-plan-to-cost-371-million.htm</link> 
  <pubDate>Thu, 21 Aug 2008 20:34:14 EDT</pubDate>
  </item>


  <item>
  <title>Genentech rejects Roche's $43.7 billion bid</title>
  <description>Biotechnology giant Genentech Inc. rejected a $43.7 billion buyout offer from its majority owner Roche on Wednesday but said it is open to a higher takeover bid.</description>
    <link>http://www.ibtimes.com/articles/20080813/genentech-rejects-roches-43-7-billion-bid.htm</link> 
  <pubDate>Wed, 13 Aug 2008 13:13:18 EDT</pubDate>
  </item>


  <item>
  <title>Genentech convenes committee to consider Roche bid</title>
  <description>Genentech Inc. says the company has officially formed a special committee consisting of its three independent board members to consider Roche Holding's takeover bid.</description>
    <link>http://www.ibtimes.com/articles/20080724/genentech-convenes-committee-to-consider-roche-bid.htm</link> 
  <pubDate>Thu, 24 Jul 2008 19:34:02 EDT</pubDate>
  </item>


  <item>
  <title>Law firm sues Roche, calls Genentech bid too low</title>
  <description>A New York law firm has sued Roche Holding AG claiming the Swiss pharmaceutical company is offering too little in its takeover bid for Genentech Inc. Cohen, Milstein, Hausfeld &amp; Toll, P.L.L.C. said it filed suit on behalf of Genentech shareholders Wednesday in Delaware's Court of Chancery alleging Roche's $89 per share bid is "unfair and inadequate."</description>
    <image>
  <url>http://www.ibtimes.com/data/articleimgs/96913-switzerland-roche-genentech.jpg</url>
  <link>http://www.ibtimes.com/articles/20080724/law-firm-sues-roche-calls-genentech-bid-too-low.htm</link>
  </image>
    <link>http://www.ibtimes.com/articles/20080724/law-firm-sues-roche-calls-genentech-bid-too-low.htm</link> 
  <pubDate>Thu, 24 Jul 2008 05:12:26 EDT</pubDate>
  </item>


  <item>
  <title>Fitch may lower Roche rating due to Genentech bid</title>
  <description>Fitch Ratings Services said Wednesday it is likely to reduce its ratings for Roche Holding AG due to the large amount of debt the Swiss drugmaker would have to take on to buy U.S. biotech giant Genentech Inc.</description>
    <link>http://www.ibtimes.com/articles/20080723/fitch-may-lower-roche-rating-due-to-genentech-bid.htm</link> 
  <pubDate>Wed, 23 Jul 2008 12:39:23 EDT</pubDate>
  </item>


  <item>
  <title>Roche gets Arius in biotech buying moves</title>
  <description>Pharmaceutical giant Roche Holding on Wednesday announced plans to buy Arius Research Inc. of Canada for $190.4 million as the latest in a series of purchases of North American biotechnology companies.</description>
    <link>http://www.ibtimes.com/articles/20080723/roche-gets-arius-in-biotech-buying-moves.htm</link> 
  <pubDate>Wed, 23 Jul 2008 06:54:22 EDT</pubDate>
  </item>


  <item>
  <title>Top Roche, Genentech officials meeting</title>
  <description>Top officials of Swiss pharmaceutical giant Roche Holding and Genentech Inc. are meeting Tuesday to discuss Roche's proposed $43.7 billion takeover bid for the U.S. biotechnology pioneer.</description>
    <link>http://www.ibtimes.com/articles/20080722/top-roche-genentech-officials-meeting.htm</link> 
  <pubDate>Tue, 22 Jul 2008 18:28:29 EDT</pubDate>
  </item>


  <item>
  <title>Roche buys Mirus Bio Corp. for $125 million</title>
  <description>Pharmaceutical company Roche Holding said Tuesday it will buy U.S. gene therapy company Mirus Bio Corp. for $125 million. The announcement came a day after Roche offered $43.7 billion for the remaining shares of U.S. biotech pioneer Genentech Inc.</description>
    <link>http://www.ibtimes.com/articles/20080722/roche-buys-mirus-bio-corp-for-us-125m.htm</link> 
  <pubDate>Tue, 22 Jul 2008 07:45:11 EDT</pubDate>
  </item>


  <item>
  <title>Genentech mulls Roche offer as stock surges</title>
  <description>Biotechnology pioneer Genentech Inc. mulled Roche Holding's $43.7 billion offer for its remaining shares Monday as investors made clear their feelings that the Swiss pharmaceutical giant should pay considerably more.</description>
    <link>http://www.ibtimes.com/articles/20080721/genentech-mulls-roche-offer-as-stock-surges.htm</link> 
  <pubDate>Mon, 21 Jul 2008 16:56:51 EDT</pubDate>
  </item>


  <item>
  <title>Roche offers $43.7B for rest of Genentech</title>
  <description>Swiss pharmaceutical maker Roche on Monday offered $43.7 billion for the remaining shares of its U.S. biotech partner Genentech Inc., seizing the opportunity offered by the weak U.S. dollar to grab a bigger share of earnings from such Genentech drugs as the blockbuster cancer treatment Avastin.</description>
    <link>http://www.ibtimes.com/articles/20080721/roche-offers-44b-for-remaining-genentech-shares.htm</link> 
  <pubDate>Mon, 21 Jul 2008 12:34:20 EDT</pubDate>
  </item>


  <item>
  <title>Roche will pay up to $774 million for cancer drug</title>
  <description>Swiss pharmaceutical giant Roche AG said Wednesday it will pay up to $774 million to Belgian biotech firm ThromboGenics NV and Swedish drugmaker BioInvent International to develop an early-stage cancer drug.</description>
    <link>http://www.ibtimes.com/articles/20080618/roche-will-pay-up-to-774-million-for-cancer-drug.htm</link> 
  <pubDate>Wed, 18 Jun 2008 09:14:08 EDT</pubDate>
  </item>


  <item>
  <title>FDA stresses birth defect risks with Roche drug</title>
  <description>Health regulators warned again Friday that Roche and Novartis drugs prescribed to organ transplant patients can cause miscarriages and birth defects when used by pregnant women.</description>
    <link>http://www.ibtimes.com/articles/20080516/fda-stresses-birth-defect-risks-with-roche-drug.htm</link> 
  <pubDate>Fri, 16 May 2008 16:56:32 EDT</pubDate>
  </item>


  <item>
  <title>Roche to transfer 300 jobs from Indiana to Germany</title>
  <description>Roche Diagnostics is transferring about 300 jobs from Indianapolis to Germany over the next three years to consolidate part of its operations. Spokeswoman Doyia Turner said Monday that the transfers will start in October and most will be completed by 2011. A limited number of employees will be offered transfers to Germany, but most will be laid off.</description>
    <link>http://www.ibtimes.com/articles/20080505/roche-to-transfer-300-jobs-from-indiana-to-germany.htm</link> 
  <pubDate>Mon, 05 May 2008 20:27:51 EDT</pubDate>
  </item>


</channel>
</rss>